Open AccessAtazanavir Plus Cobicistat (ATV + c) Versus Atazanavir Plus Ritonavir (ATV + r), Both in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF): Week 48 Subgroup Analysis of a Phase 3, Randomized, Double-Blind, Active-Controlled Trial
Author(s) -
Edwin DeJesus,
Joel E. Gallant,
Peter Shalit,
Huyen Cao,
Ya-Pei Liu,
Joel Myers,
Lisa Rosenblatt,
Lingfeng Yang,
Javier Szwarcberg
Publication year - 2015
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv133.622
Subject(s) - atazanavir , cobicistat , medicine , emtricitabine , ritonavir , double blind , elvitegravir , tenofovir , virology , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , placebo , alternative medicine , pathology